Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1971 1
1972 1
1973 1
1974 1
1975 1
1976 1
1977 3
1978 2
1981 1
1983 1
1984 1
1985 3
1986 1
1987 2
1988 3
1989 4
1992 2
1997 1
2002 1
2003 2
2004 4
2007 3
2008 1
2009 6
2010 6
2011 7
2012 8
2013 9
2014 6
2015 3
2016 4
2017 2
2018 8
2019 2
2020 1
2021 1
2022 7
2023 8
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Results by year

Filters applied: . Clear all
Page 1
Arthroscopic Pectoralis Minor Release.
Hendrix ST, Hoyle M, Tokish JM. Hendrix ST, et al. Among authors: hoyle m. Arthrosc Tech. 2018 May 7;7(6):e589-e594. doi: 10.1016/j.eats.2018.02.003. eCollection 2018 Jun. Arthrosc Tech. 2018. PMID: 29955566 Free PMC article.
BRAF inhibitors and their immunological effects in malignant melanoma.
Adams R, Coumbe JEM, Coumbe BGT, Thomas J, Willsmore Z, Dimitrievska M, Yasuzawa-Parker M, Hoyle M, Ingar S, Geh JLC, MacKenzie Ross AD, Healy C, Papa S, Lacy KE, Karagiannis SN. Adams R, et al. Among authors: hoyle m. Expert Rev Clin Immunol. 2022 Apr;18(4):347-362. doi: 10.1080/1744666X.2022.2044796. Epub 2022 Mar 3. Expert Rev Clin Immunol. 2022. PMID: 35195495 Review.
Drug safety evaluation of defibrotide.
Richardson PG, Corbacioglu S, Ho VT, Kernan NA, Lehmann L, Maguire C, Maglio M, Hoyle M, Sardella M, Giralt S, Holler E, Carreras E, Niederwieser D, Soiffer R. Richardson PG, et al. Among authors: hoyle m. Expert Opin Drug Saf. 2013 Jan;12(1):123-36. doi: 10.1517/14740338.2012.749855. Epub 2012 Dec 10. Expert Opin Drug Saf. 2013. PMID: 23228043 Review.
EMA and NICE Appraisal Processes for Cancer Drugs: Current Status and Uncertainties.
Dickson R, Boland A, Duarte R, Kotas E, Woolacott N, Hodgson R, Riemsma R, Grimm S, Ramaekers B, Joore M, Büyükkaramikli N, Kaltenthaler E, Stevenson M, Pandor A, Edwards S, Hoyle M, Shepherd J, Armoiry X, Brazzelli M. Dickson R, et al. Among authors: hoyle m. Appl Health Econ Health Policy. 2018 Aug;16(4):429-432. doi: 10.1007/s40258-018-0393-7. Appl Health Econ Health Policy. 2018. PMID: 29808296 Free PMC article. No abstract available.
Avelumab Plus Talazoparib in Patients With BRCA1/2- or ATM-Altered Advanced Solid Tumors: Results From JAVELIN BRCA/ATM, an Open-Label, Multicenter, Phase 2b, Tumor-Agnostic Trial.
Schram AM, Colombo N, Arrowsmith E, Narayan V, Yonemori K, Scambia G, Zelnak A, Bauer TM, Jin N, Ulahannan SV, Colleoni M, Aftimos P, Donoghue MTA, Rosen E, Rudneva VA, Telli ML, Domchek SM, Galsky MD, Hoyle M, Chappey C, Stewart R, Blake-Haskins JA, Yap TA. Schram AM, et al. Among authors: hoyle m. JAMA Oncol. 2023 Jan 1;9(1):29-39. doi: 10.1001/jamaoncol.2022.5218. JAMA Oncol. 2023. PMID: 36394867 Free PMC article.
Inhibition of chlorine-induced airway fibrosis by budesonide.
Musah S, Chen J, Schlueter C, Humphrey DM Jr, Stocke K, Hoyle MI, Hoyle GW. Musah S, et al. Among authors: hoyle mi. Toxicol Appl Pharmacol. 2019 Jan 15;363:11-21. doi: 10.1016/j.taap.2018.08.024. Epub 2018 Sep 3. Toxicol Appl Pharmacol. 2019. PMID: 30189237 Free PMC article.
Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Care Excellence Single Technology Appraisal.
Tikhonova IA, Jones-Hughes T, Dunham J, Warren FC, Robinson S, Stephens P, Hoyle M. Tikhonova IA, et al. Among authors: hoyle m. Pharmacoeconomics. 2018 Jan;36(1):39-49. doi: 10.1007/s40273-017-0568-3. Pharmacoeconomics. 2018. PMID: 28914440 Review.
109 results